Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 304,767	$ 504,389
Restricted cash	1,472	3,345
Investments	119,543	3,212
Trade receivables	50,599	29,413
Inventory, net	27,533	15,791
Prepaid expenses and other current assets	12,586	9,986
Total current assets	516,500	566,136
Property and equipment, net	8,617	8,714
Long-term investments	18,077	6,829
Other assets	6,806	6,472
Total assets	550,000	588,151
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Accounts payable	14,356	27,808
Accrued expenses	87,565	72,670
Deferred revenue	1,224	1,421
Lease financing obligation	2,369	1,819
Total current liabilities	105,514	103,718
Lease financing obligation	5,804	5,962
Royalty financing obligations	501,655	449,375
Secured term loan	231,624	136,082
Stockholders’ deficit:
Preferred stock, $0.01 par value; shares authorized — 5,000; no shares outstanding	0	0
Common stock, $0.01 par value; shares authorized — 450,000; Issued and outstanding – 187,906 and 184,350 at December 31, 2022 and 2021, respectively	1,879	1,843
Additional paid-in capital	1,158,118	1,098,498
Accumulated other comprehensive income	26	177
Accumulated deficit	(1,454,620)	(1,207,504)
Total stockholders’ deficit	(294,597)	(106,986)
Total liabilities and stockholders’ deficit	$ 550,000	$ 588,151